Arcturus Therapeutics Stock (NASDAQ: ARCT) stock price, news, charts, stock research, profile.
Open | $26.090 |
Close | - |
Volume / Avg. | 147.420K / 478.082K |
Day Range | 25.410 - 26.380 |
52 Wk Range | 17.520 - 43.810 |
Market Cap | $708.678M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 23.8% |
Days to Cover | 8.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Arcturus Therapeutics (NASDAQ: ARCT) through any online brokerage.
Other companies in Arcturus Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), 89bio (NASDAQ:ETNB), Zentalis Pharma (NASDAQ:ZNTL) and Cogent Biosciences (NASDAQ:COGT).
The latest price target for Arcturus Therapeutics (NASDAQ: ARCT) was reported by HC Wainwright & Co. on Wednesday, March 20, 2024. The analyst firm set a price target for 60.00 expecting ARCT to rise to within 12 months (a possible 122.39% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $26.98 last updated April 24, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Arcturus Therapeutics.
Arcturus Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Arcturus Therapeutics.
Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.